amlodipine besylate and atorvastatin calcium (Ranbaxy Pharmaceuticals Inc)
Welcome to the PulseAid listing for the amlodipine besylate and atorvastatin calcium drug offered from Ranbaxy Pharmaceuticals Inc. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | amlodipine besylate and atorvastatin calcium |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2011-12-06 |
| END MARKETING DATE: | 0000-00-00 |
amlodipine besylate and atorvastatin calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | amlodipine besylate and atorvastatin calcium from Ranbaxy Pharmaceuticals Inc |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 80(mg/1; mg/1) |
| START MARKETING DATE: | 2011-12-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-499_637c6e1b-099a-4f59-8a06-ca38456862a7 |
| PRODUCT NDC: | 63304-499 |
| APPLICATION NUMBER: | NDA021540 |
Other AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE Pharmaceutical Manufacturers / Labelers:
